Are activated T cells regulators of bone metabolism in children with Crohn disease?

Journal of Pediatrics

Volumn 148, Issue 4, 2006, Pages 461-466

  Sylvester, Francisco A ^a,b,c   Davis, Patricia M ^a,b,c   Wyzga, Nancy ^a,b,c   Hyams, Jeffrey S ^a,b,c   Lerer, Trudy ^a,b,c  

^a Farmington   (United States)

^b SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ARTICLE; BODY MASS; BONE AGE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE REMODELING; BONE TURNOVER; CHEMICAL ANALYSIS; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; FEMALE; HUMAN; MALE; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; BONE RESORPTION; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHILD; CROHN DISEASE; CYTOKINES; FEMALE; GLYCOPROTEINS; HUMANS; INTERFERON TYPE II; LOGISTIC MODELS; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES;

EID: 33646076735     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.12.027     Document Type: Article

References (33)

1. Kong Y.Y., Feige U., Sarosi I., Bolon B., Tafuri A., Morony S., et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402 (1999) 304-309
2. Takayanagi H., Ogasawara K., Hida S., Chiba T., Murata S., Sato K., et al. T-cell-mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and IFN-γ. Nature 408 (2000) 600-605
3. Kotake S., Udagawa N., Hakoda M., Mogi M., Yano K., Tsuda E., et al. Activated human T cells directly induce osteoclastogenesis from human monocytes. possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 44 (2001) 1003-1012
4. Weitzmann M.N., Cenci S., Rifas L., Haug J., Dipersio J., and Pacifici R. T-cell activation induces human osteoclast formation via receptor activator of nuclear factor kappa B ligand-dependent and -independent mechanisms. J Bone Miner Res 16 (2001) 328-337
5. Udagawa N. The mechanism of osteoclast differentiation from macrophages. possible roles of T lymphocytes in osteoclastogenesis. J Bone Miner Metab 21 (2003) 337-343
6. Bernstein C.N., and Leslie W.D. Review article. osteoporosis and inflammatory bowel disease. Aliment Pharmacol Ther 19 (2004) 941-952
7. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397 (1999) 315-323
8. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95 (1998) 3597-3602
9. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., et al. Osteoprotegerin. a novel secreted protein involved in the regulation of bone density. Cell 89 (1997) 309-319
10. Smith D.D., Gowen M., and Mundy G.R. Effects of interferon-gamma and other cytokines on collagen synthesis in fetal rat bone cultures. Endocrinology 120 (1987) 2494-2499
11. Kim S., Koga T., Isobe M., Kern B.E., Yokochi T., Chin Y.E., et al. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev 17 (2003) 1979-1991
12. Chen R.M., Chen T.L., Chiu W.T., and Chang C.C. Molecular mechanism of nitric oxide-induced osteoblast apoptosis. J Orthop Res 23 (2005) 462-468
13. Fuss I., Neurath M., Boirivant M., Klein J., de la Motte C., Strong S., et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157 (1996) 1261-1270
14. Franchimont N., Reenaers C., Lambert C., Belaiche J., Bours V., Malaise M., et al. Increased expression of receptor activator of NF-kappa B ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clin Exp Immunol 138 (2004) 491-498
15. van der Sluis I.M., de Ridder M.A., Boot A.M., Krenning E.P., and de Muinck Keizer-Schrama S.M. Reference data for bone density and body composition measured with dual-energy x-ray absorptiometry in white children and young adults. Arch Dis Child 87 (2002) 341-347
16. Greulich W.W., and Pyle S.I. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. (1959), Stanford University Press, Stanford, CA
17. Hyams J.S., Ferry G.D., Mandel F.S., Gryboski J.D., Kibort P.M., Kirschner B.S., et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 12 (1991) 439-447
18. Burnham J.M., Shults J., Semeao E., Foster B., Zemel B.S., Stallings V.A., et al. Whole body BMC in pediatric Crohn disease. independent effects of altered growth, maturation, and body composition. J Bone Miner Res 19 (2004) 1961-1968
19. Kleinbaum D.G., Kupper L.L., and Muller K.E. Applied regression analysis and other multivariable methods. 2nd ed. (1988), Duxbury Press, Belmont, CA
20. Bjarnason I., Macpherson A., Mackintosh C., Buxton-Thomas M., Forgacs I., and Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 40 (1997) 228-233
21. Robinson R.J., Iqbal S.J., Abrams K., Al-Azzawi F., and Mayberry J.F. Increased bone resorption in patients with Crohn's disease. Aliment Pharmacol Ther 12 (1998) 699-705
22. Schulte C., Dignass A.U., Mann K., and Goebell H. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflamm Bowel Dis 4 (1998) 268-275
23. Dresner-Pollak R., Karmeli F., Eliakim R., Ackerman Z., and Rachmilewitz D. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease. Am J Gastroenterol 95 (2000) 699-704
24. Salmi M., and Jalkanen S. Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules. J Immunol 166 (2001) 4650-4657
25. Shen V., Kohler G., Jeffrey J.J., and Peck W.A. Bone-resorbing agents promote and interferon-gamma inhibits bone cell collagenase production. J Bone Miner Res 3 (1988) 657-666
26. Wyzga N., Varghese S., Wikel S., Canalis E., and Sylvester F.A. Effects of activated T cells on osteoclastogenesis depend on how they are activated. Bone 35 (2004) 614-620
27. Byrne F.R., Morony S., Warmington K., Geng Z., Brown H.L., Flores S.A., et al. CD4+CD45RBHi T-cell transfer-induced colitis in mice is accompanied by osteopenia that is treatable with recombinant human osteoprotegerin. Gut 54 (2005) 78-86
28. Bernstein C.N., Sargent M., and Leslie W.D. Serum osteoprotegerin is increased in Crohn's disease. a population-based case control study. Inflamm Bowel Dis 11 (2005) 325-330
29. Vidal K., Serrant P., Schlosser B., van den Broek P., Lorget F., and Donnet-Hughes A. Osteoprotegerin production by human intestinal epithelial cells. a potential regulator of mucosal immune responses. Am J Physiol Gastrointest Liver Physiol 287 (2004) G836-G844
30. Hyams J.S., Wyzga N., Kreutzer D.L., Justinich C.J., and Gronowicz G.A. Alterations in bone metabolism in children with inflammatory bowel disease. an in vitro study. J Pediatr Gastroenterol Nutr 24 (1997) 289-295
31. Sylvester F.A., Wyzga N., Hyams J.S., and Gronowicz G.A. Effect of Crohn's disease on bone metabolism in vitro. a role for interleukin-6. J Bone Miner Res 17 (2002) 695-702
32. Varghese S., Wyzga N., Griffiths A.M., and Sylvester F.A. Effects of serum from children with newly diagnosed Crohn disease on primary cultures of rat osteoblasts. J Pediatr Gastroenterol Nutr 35 (2002) 641-648
33. Szulc P., Seeman E., and Delmas P.D. Biochemical measurements of bone turnover in children and adolescents. Osteoporos Int 11 (2000) 281-294